Chris O'Meara, Associated Press
NEW BRUNSWICK, N.J. — Johnson & Johnson says its first-quarter profit rose 8 percent, because of restrained costs and a big jump in prescription drug sales. The world's biggest maker of health care products easily beat Wall Street expectations and raised its earnings outlook.
The maker of Tylenol, medical devices and prescription drugs said Tuesday that net income was $4.73 billion, or $1.64 per share, up from $3.5 billion, or $1.22 per share, a year earlier.
Excluding one-time items, income was $4.43 billion, or $1.54 per share. Analysts surveyed by FactSet expected $1.48.
Revenue totaled $18.12 billion, up 3.5 percent. Analysts expected $18.04 billion.
The company, based in New Brunswick, N.J., raised its profit forecast for 2014 to $5.80 to $5.90 per share. In January, J&J forecast $5.75 to $5.85.
- Zika mosquito: thrives in hot weather, hard...
- Mosquitoes have apparently begun spreading...
- 7 tips for summer travel while pregnant
- The sobering reason parents should never take...
- How Zika gets into a baby's brain
- Drowning in grief: How one mother learned to...
- Arianne Brown: A taste of humble pie and ice...
- Planned Parenthood 'CTR' campaign draws ire
- Planned Parenthood 'CTR' campaign draws... 64
- Utah communities are working to stop... 5
- Utah Lake reopens for boating; advisory... 2
- Zika mosquito: thrives in hot weather,... 1
- Mosquitoes have apparently begun... 0
- 7 tips for summer travel while pregnant 0
- The sobering reason parents should... 0
- How Zika gets into a baby's brain 0